Allucent Contract Research Organization
-
Exceptional clinical trial execution and delivery on milestones
-
Unmatched therapeutic proficiency
-
Deep consulting expertise- Regulatory strategy and submissions
- Clinical pharmacology, modeling & simulation
- Biostatistics, & statistical programming
Get Started with a Customized Clinical Solution
Why Allucent?
Allucent was specifically built to meet the very unique needs of the small to mid-size biotech. Our range of capabilities is equivalent to that of large contract research organizations, but with the expertise and specialization of niche CROs. Through extraordinary attention to detail and focused operational efficiency we deliver to your milestones. We anticipate and mitigate problems before they happen and our nimble philosophy allows us to pivot to your needs quickly.
Therapeutic Expertise
You treat the most complex and challenging diseases. We’ve assembled expert, multidisciplinary teams to support your specific therapeutic need.
Exceptional Clinical Trial Delivery
Allucent’s flexible clinical development and regulatory solutions enable our partners to successfully navigate the complexities of managing and conducting early and late-stage multi-national programs.
Robust Consulting
From biostatistical consulting to regulatory strategy and clinical pharmacology, Allucent has a deep bench of experts to tackle these critically important gates to improve efficiencies and take your drug to market faster.
Exceptional Clinical Trial Delivery
Anchored by deep expertise and a high-touch partnership model, Allucent delivers operational excellence across a breadth of specialized services and therapeutic experience geared toward small and mid-sized biotech companies.
Testimonials
We recently hired Allucent as our global CRO on an extremely complex cell therapy program in oncology. In the bid process they went above and beyond any CRO I've worked with to respond to questions, collaborate and even advise us to a degree that it seemed like they had thought about the program as much as we had.
We worked hand-in-hand with Allucent's regulatory strategy experts to support the 510(k) approval and CLIA Waiver of a cutting edge in-vitro diagnostic. Allucent's experts were instrumental in navigating the interactive review process with FDA and we are eager to continue our relationship into the future.
"We benefited greatly from their deep experience and their professional, yet comfortable working relationship. The most impressive part about working with Allucent is that they can be trusted to deliver what they promise.
Robust Consulting
From study design and biostatistical programming to regulatory strategy and clinical pharmacology, Allucent has a deep bench of experts to tackle these critically important gates to improve efficiencies and take your drug to market faster.
With former global regulators from the FDA, EMA, and other authorities, our A-Team boasts in-depth knowledge of all regulatory requirements and processes allowing us to optimize your regulatory pathway to maximize the chances for first-time approval.
By translating complex data into actionable insights that informs dosing, study designs, and modeling, we help deliver on your next breakthrough.
With expertise in study design, endpoint selection, and statistical analysis, our biostatistics experts provide strategic insights to guide your clinical development process.
Therapeutic Expertise
The Allucent Centers of Expertise (ACEs) are designed, structured, and resourced to deliver comprehensive trial and regulatory strategy; effective patient-focused recruitment plans; and solutions that meet your specific needs.
Leadership
About Us
A Fully Integrated Global Company
Allucent delivers innovative strategies and robust solutions based on over 30 years of background in regulatory trends, therapeutic experience, and operational expertise. We share small and mid-sized companies’ deep commitment to supporting breakthrough science by partnering with them to navigate the complexities of delivering novel treatments to patients.
With offices across North America, Europe, and the Middle East, Allucent has experience conducting trials in more than 75 countries, focusing on some of the most complex development areas. Globally, Allucent has worked on more than 825 clinical trials, with oncology representing the majority.
Frequently Asked Questions
A lot, actually. Allucent was specifically built to meet the very unique needs of the small to mid-size Biotech. Our range of capabilities is equivalent to that of large contract research organizations, but with the expertise and specialization of niche CROs. Through extraordinary attention to detail and focused operational efficiency we deliver to your milestones. We anticipate and mitigate problems before they happen and our nimble philosophy allows us to pivot to your needs quickly.
The most efficient and effective way to evaluate why Allucent is the best CRO for your drug development program is to click this link. It takes you to a form where you answer a few questions, then one of our A-Team experts will reach out to you within 24 hours. That kicks off a process where we get a comprehensive understanding of your needs, and we come back to you with a detailed proposal for how Allucent will be the best partner to ensure your success.
The Allucent brand is only 3 years old. In actuality, we’ve been around for almost 40 years. After a series of acquisitions and mergers, Allucent is purpose-built and the sum total of CATO Research (1988), SMS Oncology (1994), Pharm-Olam (2007), Nuventra (2008), Array Biostatistics (2012), and CATO-SMS (2019).
